Epstein-Barr virus (EBV) is the first human tumor virus discovered and is strongly implicated
in the etiology of multiple lymphoid and epithelial cancers. Each year EBV associated …

EBV is a prevalent virus, infecting> 90% of the world's population. This is an oncogenic virus
that causes~ 200,000 cancer-related deaths annually. It is, in addition, a significant …

The recent emergence of a causal link between Epstein-Barr virus (EBV) and multiple
sclerosis has generated considerable interest in the development of an effective vaccine …

Epstein–Barr virus (EBV) was the first tumor virus in humans. Nasopharyngeal carcinoma
(NPC) accounts for approximately 60% of the 200,000 new tumor cases caused by EBV …

Epstein–Barr virus-associated diseases are important global health concerns. As a group I
carcinogen, EBV accounts for 1.5% of human malignances, including both epithelial-and …

Nasopharyngeal carcinoma (NPC) is an epithelial tumor located in the nasopharynx and is
highly associated with Epstein‑Barr virus (EBV) infection. Although radiotherapy alone can …

The incidence of nasopharyngeal carcinoma (NPC) exhibits significant variations across
different ethnic groups and geographical regions, with Southeast Asia and North Africa …

The Epstein–Barr virus (EBV) can cause different types of cancer in human beings when the
virus infects different cell types with various latent patterns. EBV shapes a distinct and …

Background: Infectious mononucleosis is common among adolescents and young adults.
Although the majority of cases resolve spontaneously, life-threatening manifestations, and …

Epstein‐Barr virus (EBV) is associated with various malignancies and infects> 90% of the
global population. EBV latent proteins are expressed in numerous EBV‐associated cancers …